Gilead Sciences Inc.: Best Buy In The Market?

For Gilead, the street is looking for earnings of $3.02/share on $7.85 billion in revenue. The bar appears to have been set quite low for the quarter, and the future for that matter.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.